PROHANCE 0.5 mmol/ml, solution for injection in a pre-filled syringe syringe, 17 ml, CIP 3400930011881
Active ingredients: Gadoteridol
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 17 ml, CIP 3400930011881intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROHANCE 0,5 mmol/mL, solution injectable en seringue pré-remplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 17 ml avec nécessaire d’administration pour injecteur automatique Spectris Solaris (seringue, raccord, perforateur et cathéter).
- Marketing authorisation holder
- BRACCO IMAGING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Mar 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61258225CIP73001188CIP133400930011881Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GADOTÉRIDOLsolution | 279,3 mg · 1 mL de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.